https://www.selleckchem.com/products/AC-220.html
There is a little evidence that routine follow-up of patients treated for early breast cancer (BC) to detect ibsilateral breast tumour recurrence (IBTR), or contralateral breast cancer (CBC), is either effective or offers any mortality benefits. We report our experience of following patients with early BC for recurrences and new primaries in order to determine the role of mammogram surveillance. Single centre, retrospective primary observational study was designed. Patients who had BC during year 2001-2006 were included and followed for
Like
Comment
Share